Maryland will receive $849,259 under a multistate False Claims Act settlement the federal government reached with an India-based generic drug maker in U.S. District Court in Baltimore, the state Office of the Attorney General said Monday.
Tagged with: drugmaker False Claims Act FDA indian Law legal news maryland u.s. food and drug administration
Read More »